EXECUTIVE INTERVIEW – Owen Mumford & Stevanato Group: Collaborating to Produce Aidaptus® Auto-injector
Drug Development & Delivery
Drug Development & Delivery has over 26,000 digital and print subscribers and connects technology and service providers with R&D scientists/managers, business development professionals and corporate managers working in pharmaceutical and biotechnology companies worldwide. The website boasts 46,000 average monthly visitors.
Drug Development & Delivery recently interviewed Michael Earl, Director of Pharmaceutical Services at Owen Mumford, and Steven Kaufman, Vice President for Drug Delivery Systems at Stevanato Group to discuss their collaboration in producing the innovative Aidaptus auto-injector.
Read the full Executive Interview below